Annual Report on the External Quality Assessment Scheme for Transfusion Medicine in Korea (2017)
Journal of Laboratory Medicine and Quality Assurance
; : 9-20, 2018.
Article
de Ko
| WPRIM
| ID: wpr-713615
Bibliothèque responsable:
WPRO
ABSTRACT
Here, we have reported results of the surveys on the external quality assessment scheme (EQA) of the Transfusion Medicine Program (TMP) in Korea that were carried out in 2017. The proficiency testing specimens were prepared at Ajou University Hospital, and sent to the participants biannually. The average accuracy rates (N=the number of participants) for ten different test items on the regular survey were as follows: ABO typing, 99.1%–99.9% (N=714); RhD typing, 99.3%–100.0% (N=695); crossmatching, 88.9%–98.5% (N=618); ABO subtyping, 80.7% and 96.0% (N=51); Rh CcEe antigen testing, 98.8%–100.0% (N=51); weak D test, 99.3% and 100.0 (N=150); antibody screening, 98.6%–100.0% (N=295); direct antiglobulin test (DAT) using a poly-specific reagent, 99.2%–100.0 (N=256); DAT using an immunoglobulin-G monospecific reagent, all 100.0% (N=68); DAT using a C3d-monospecific reagent, 83.6%–100.0% (N=72); antibody identification, 88.7%–99.2% (N=123); and ABO Ab titration, 84.6%–100.0% (N=73). The number of participants for the EQA for TMP in 2017 was much higher than that in 2016. Except for the case of ABO subtyping, excellent survey results for the 2017 EQA for TMP were obtained, compared to those in 2016. Thus, the EQA for TMP in 2017 should be helpful for improving the quality of the participating laboratories.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Thymidine monophosphate
/
Test de Coombs
/
Dépistage de masse
/
Amélioration de la qualité
/
Évaluation de la compétence des laboratoires
/
Médecine transfusionnelle
/
Corée
Type d'étude:
Screening_studies
Pays comme sujet:
Asia
langue:
Ko
Texte intégral:
Journal of Laboratory Medicine and Quality Assurance
Année:
2018
Type:
Article